| Dr Walter Max Adam, MD | |
|
Corner Of Route N12 And N7, Fort Defiance, AZ 86504 | |
| (928) 729-8000 | |
| Not Available |
| Full Name | Dr Walter Max Adam |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | Corner Of Route N12 And N7, Fort Defiance, Arizona |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053368860 | NPI | - | NPPES |
| 1053368860 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 2011024400 (Missouri) | Secondary |
| 207Q00000X | Family Medicine | 352304-1205 (Utah) | Primary |
| Entity Name | State Of Utah |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811978620 PECOS PAC ID: 6800797333 Enrollment ID: O20040117000195 |
News Archive
The U.S. Food and Drug Administration today approved Ultomiris (ravulizumab) injection for the treatment of adult patients with paroxysmal nocturnal hemoglobinuria (PNH), a rare and life-threatening blood disease.
This past October, 214 researchers from the U.S., Europe, and Australia, as well as representatives of families with aggressive genetic forms of Alzheimer disease (AD), met at Washington University, St. Louis, Missouri, to devote two intense days of talks and discussion to their goal of detecting this disease before symptoms appear. By a growing consensus, defining the "silent" phase of AD has become the field's central challenge if it is to modernize drug testing and lay the groundwork for AD prevention trials.
Myths about the infectious disease threat posed by dead bodies could lead to insensitive and inappropriate treatment of victims' bodies following the floods in Haiti, and need to be checked, according to a public health researcher who has studied the potential risks at length.
Using proteomics techniques to study injured optic nerves, researchers at Boston Children's Hospital have identified previously unrecognized proteins and pathways involved in nerve regeneration. Adding back one of these proteins-the oncogene c-myc-they achieved unprecedented optic nerve regeneration in mice when combined with two other known strategies.
A collaboration of University of Pennsylvania and University of Wisconsin chemists and anesthesiologists have identified a fluorescent anesthetic compound that will assist researchers in obtaining more precise information about how anesthetics work in the body and will provide a means to more rapidly test new anesthetic compounds in the search for safer and more effective drugs.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Walter Max Adam, MD 11572 S Lake Run Rd, South Jordan, UT 84009-8784 Ph: () - | Dr Walter Max Adam, MD Corner Of Route N12 And N7, Fort Defiance, AZ 86504 Ph: (928) 729-8000 |
News Archive
The U.S. Food and Drug Administration today approved Ultomiris (ravulizumab) injection for the treatment of adult patients with paroxysmal nocturnal hemoglobinuria (PNH), a rare and life-threatening blood disease.
This past October, 214 researchers from the U.S., Europe, and Australia, as well as representatives of families with aggressive genetic forms of Alzheimer disease (AD), met at Washington University, St. Louis, Missouri, to devote two intense days of talks and discussion to their goal of detecting this disease before symptoms appear. By a growing consensus, defining the "silent" phase of AD has become the field's central challenge if it is to modernize drug testing and lay the groundwork for AD prevention trials.
Myths about the infectious disease threat posed by dead bodies could lead to insensitive and inappropriate treatment of victims' bodies following the floods in Haiti, and need to be checked, according to a public health researcher who has studied the potential risks at length.
Using proteomics techniques to study injured optic nerves, researchers at Boston Children's Hospital have identified previously unrecognized proteins and pathways involved in nerve regeneration. Adding back one of these proteins-the oncogene c-myc-they achieved unprecedented optic nerve regeneration in mice when combined with two other known strategies.
A collaboration of University of Pennsylvania and University of Wisconsin chemists and anesthesiologists have identified a fluorescent anesthetic compound that will assist researchers in obtaining more precise information about how anesthetics work in the body and will provide a means to more rapidly test new anesthetic compounds in the search for safer and more effective drugs.
› Verified 2 days ago
Rodney Wilson Cuny, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: Corner Of Route N12 And N7, Fort Defiance, AZ 86504 Phone: 928-729-8000 | |
Naomi Jean Young, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: Corner Of Route N12 And N7, Fort Defiance, AZ 86504 Phone: 928-729-8000 Fax: 928-729-8169 | |
John William Whitaker, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: Corner Of Route N12 And N7, Fort Defiance, AZ 86504 Phone: 928-729-8000 | |
Dr. Marek Marcinkiewicz, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: Corner Of Route N7 & N12, Tsehootsooi Med Ctr, Fort Defiance, AZ 86504 Phone: 928-729-8130 Fax: 928-729-8669 | |
Benjamin Dodge, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: Fort Defiance Indian Hospital Board Inc., Corner Of Routes N12 & N7, Fort Defiance, AZ 86504 Phone: 928-729-8097 | |
Roger Victor Begay, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: Corner Of Route N12 And N7, Fort Defiance, AZ 86504 Phone: 928-729-8000 |